WallStreetZenWallStreetZen

NASDAQ: AADI
Aadi Bioscience Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

AADI past revenue growth

How has AADI's revenue growth performed historically?
Company
60.06%
Industry
148.64%
Market
17.33%
AADI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
AADI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
AADI's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

AADI earnings and revenue history

Current Revenue
$24.4M
Current Earnings
-$65.8M
Current Profit Margin
-270%

AADI Return on Equity

Current Company
-52.5%
Current Industry
-63.5%
Current Market
188%
AADI's Return on Equity (-52.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when AADI announces earnings.

AADI Return on Assets

Current Company
-44.3%
Current Industry
2.9%
AADI is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

AADI Return on Capital Employed

Current Company
-61.81%
Current Industry
19.5%
AADI's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AADI vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
AADI$24.35M-$64.90M-$65.77M+3.85%N/A
INAB$0.00-$27.51M-$30.01MN/AN/A
BLRX$4.80M-$57.06M-$60.61MN/AN/A
JAGX$9.76M-$32.53M-$41.30M+17.19%N/A
CDTX$63.91M-$21.21M-$22.93M+32.21%N/A
View Top Biotech Stocks

AADI earnings dates

Next earnings date
May 8, 2024

Aadi Bioscience Earnings & Revenue FAQ

What were AADI's earnings last quarter?

On Invalid Date, Aadi Bioscience (NASDAQ: AADI) reported Q4 2023 earnings per share (EPS) of -$0.60, up 25% year over year. Total Aadi Bioscience earnings for the quarter were -$16.27 million. In the same quarter last year, Aadi Bioscience's earnings per share (EPS) was -$0.48.

If you're new to stock investing, here's how to buy Aadi Bioscience stock.

What was AADI's earnings growth in the past year?

As of Q2 2024, Aadi Bioscience's earnings has grown year over year. Aadi Bioscience's earnings in the past year totalled -$65.77 million.

What is AADI's earnings date?

Aadi Bioscience's earnings date is Invalid Date. Add AADI to your watchlist to be reminded of AADI's next earnings announcement.

What was AADI's revenue last quarter?

On Invalid Date, Aadi Bioscience (NASDAQ: AADI) reported Q4 2023 revenue of $6.33 million up 21.03% year over year. In the same quarter last year, Aadi Bioscience's revenue was $5.23 million.

What was AADI's revenue growth in the past year?

As of Q2 2024, Aadi Bioscience's revenue has grown 60.06% year over year. This is 88.58 percentage points lower than the US Biotechnology industry revenue growth rate of 148.64%. Aadi Bioscience's revenue in the past year totalled $24.35 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.